Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Bortezomib
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 3.5 mg
- Dosage form
- Injection
- Pack
- 1's
- Registration no.
- 115690
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Bortoma 3.5 mg injection
Bortoma 3.5 mg injection contains Bortezomib 3.5 mg. It is registered with DRAP by Hakimsons (Pvt)., Ltd (registration no. 115690). Its official price is PKR 56,200.59 for a pack of 1's. The price changed from PKR 53,554.97 to PKR 56,200.59 on 20 August 2026. 10 other brands of Bortezomib 3.5 mg (injection) are registered in Pakistan. Compare all brands and prices →
All 10 other brands of Bortezomib 3.5 mg injection in Pakistan
These 10 brands are alternatives (substitutes) to Bortoma: each contains Bortezomib 3.5 mg injection. Ask your doctor or pharmacist before you switch brands.
Sorted by price per vial, lowest first. The lowest is Bortezomib (Atco Pharma International (Pvt) Ltd) at PKR 28,175 per vial; the highest is Veltezo at PKR 59,726. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Bortezomib | Atco Pharma International (Pvt) Ltd | 1 vial | PKR 28,175.00 | PKR 28,175 / vial |
| Pfizer Bortezomib | Pfizer Pakistan Limited | 1's | PKR 36,773.62 | PKR 36,774 / vial |
| Alvocade Single Use | Gene-Tech Laboratories | 1’s | PKR 37,198.10 | PKR 37,198 / vial |
| Fonkozomib | Amgomed | 1's | PKR 37,198.10 | PKR 37,198 / vial |
| Protezomib | AJM Pharma (Pvt.) Limited | 1's | PKR 37,928.31 | PKR 37,928 / vial |
| Bortezomib Pharmidea | Himmel Pharmaceuticals Private Limited | 1's | PKR 45,241.34 | PKR 45,241 / vial |
| Cytomib | Helix Pharma (Pvt)., Ltd | 1's | PKR 48,623.87 | PKR 48,624 / vial |
| BORTESOH | AJM Pharma (Pvt.) Limited | 1's | PKR 55,096.75 | PKR 55,097 / vial |
| M-Prib-3.5 | Lab Diagnostic Systems (SMC) Pvt. Ltd | 1's | PKR 58,993.93 | PKR 58,994 / vial |
| Veltezo | Martin Dow Limited | 1's | PKR 59,725.53 | PKR 59,726 / vial |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Bortoma, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Hakimsons (Pvt)., Ltd., Karachi
- DRAP registration
- 115690
- Phone
- +92 21 32570182; +92 21 32570183
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
PKR 53,554.97 to 56,200.59 (+4.9%) between 1 Jul 2025 and 20 Aug 2026 · 2 official price records · pack 1's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Bortoma 3.5 mg, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/bortoma-3-5-mg-115690-1s-hakimsons-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 56,200.59 | 2026-08-20 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 53,554.97 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Cite this record
Medicine record · DRAP registration 115690Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.